- $65.29m
- $60.37m
- $25.10m
Annual income statement for XCHG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 13.2 | 29.4 | 38.5 | 42.2 | 25.1 |
| Cost of Revenue | |||||
| Gross Profit | 4.78 | 10.7 | 17.7 | 21.2 | 11.6 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 15.1 | 27.8 | 45 | 54 | 57.7 |
| Operating Profit | -1.93 | 1.65 | -6.52 | -11.8 | -32.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2.07 | 1.6 | -8.08 | -11.9 | -32.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.07 | 1.61 | -8.08 | -11.9 | -32.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.07 | 1.61 | -8.08 | -11.9 | -32.5 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.07 | 0.028 | -10.5 | -13.1 | -32.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | 0 | -0.004 | -0.01 | -0.012 |